Open Call for Patient Input – Joint Assessment on a Medicinal Product for UC.
EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of adult patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response with. lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contraindications to such therapies.
To find out about participation, please read more here.
Input submissions will be received through till end of March.